“Most of the reports received in the third quarter of this year concerned mild suspected adverse reactions, which comprised 90.5 percent of the total. As regards severe adverse reactions, there were 115 reports received or 9.5 percent of the total,” SMCA director Gytis Andrulionis said.
The agency also received seven reports about deaths following vaccination in Lithuania and one report about death after vaccination outside Lithuania. Most of those deaths were due to cardiovascular diseases.
“The causal link between these deaths and the vaccine remains unconfirmed,” SMCA director said.
Out of the total number of reports on adverse reactions received in the third quarter, 636 reports were related to the Pfizer/BioNTech vaccine, 145 had to do with the Moderna vaccine, 192 – with the AstraZeneca vaccine, and 225 were linked to the Janssen vaccine.
Some 5,500 reports on adverse reactions to vaccines were received between January and September, which accounted for 0.18 percent of the total number of vaccine shots administered.
“We actually have total numbers available, how many adverse reactions have been recorded over nine months of vaccination this year. Overall, the SMCA received 5,505 reports on suspected adverse reactions by September 30,” Andrulionis said at a news conference on Friday.
Adverse reactions were reported in people aged from 12 to 95.
In most cases, adverse reactions were reported by vaccinated people themselves.
The most common adverse reactions included pain, swelling, or redness where the vaccine was injected, chills, headache and fever, which usually went away in a few days.